We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8308:TSEResona Holdings, Inc. Analysis

Data as of 2026-03-10 - not real-time

¥1,808.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Resona Holdings is trading at ¥1,808, which sits below its 20‑day SMA of ¥1,919.7 but above the 50‑day SMA of ¥1,794.8, indicating a short‑term pull‑back within a broader uptrend confirmed by the 200‑day SMA of ¥1,522.8. The RSI of 47.5 suggests neutral momentum, while the MACD remains in a bearish configuration with a negative histogram, warning of possible downside pressure. Nonetheless, the price remains comfortably above the identified support level of ¥1,642.5 and well under the 52‑week high of ¥2,193, giving the stock room to recover. Volatility is high at 58% over the past 30 days, and the market sentiment is in the “Extreme Greed” zone (Fear‑Greed Index 80.75), which could amplify short‑term moves.
Fundamentally, Resona delivers robust growth with a 24.3% revenue increase and healthy operating (39%) and profit margins (24.8%). The return on equity of 9.4% and a solid dividend yield of 1.66% (payout ratio 26.5%) underscore its profitability and cash‑generating capacity. Valuation is roughly in line with peers – a PE of 17.1 versus the industry average of 17.3 – and analysts collectively rate the stock as a Buy with a median target of ¥1,850, implying modest upside of about 2‑3% from current levels.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price near short‑term support but above key moving averages
  • Bearish MACD indicating near‑term downside risk
  • High volatility could cause rapid price swings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of 24% and strong operating margins
  • Dividend yield of 1.66% with low payout ratio
  • Target price median above current price suggesting modest upside

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Solid balance sheet with cash exceeding debt
  • Stable dividend and reasonable valuation relative to peers
  • Sector headwinds for regional Japanese banks may limit aggressive appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth24.30%
Profit Margin24.78%
P/E Ratio17.1
ROE9.39%
ROA0.35%
P/B Ratio1.4
Industry P/E17.3

Technical Analysis

TrendBullish
RSI47.5
Support¥1,642.50
Resistance¥2,193.00
MA 20¥1,919.73
MA 50¥1,794.78
MA 200¥1,522.78
MACDBearish
VolumeStable
Fear & Greed Index80.75

Valuation

Target Price¥1,884.55
Upside/Downside4.23%
GradeFair
TypeBlend
Dividend Yield1.66%

Risk Assessment

Beta0.87
Volatility58.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.